SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PROK

Prokidney Corp. (NASDAQ:PROK)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.39-0.02 (-1.42%)
 
Market cap
$467M
Analyst consensus
Listed since
Jun 30, 2021
Insider Score
––Not scored
PROK Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

PROK Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue150.00 K226.00 K225.00 K217.00 K221.00 K230.00 K
Revenue Growth (YoY)-32.13 %-1.74 %196.05 %———
Cost of Revenue0.001.44 M1.45 M0.000.000.00
Gross Profit150.00 K-1.21 M-1.22 M217.00 K221.00 K230.00 K
SG&A Expense12.43 M11.32 M6.26 M11.94 M14.05 M14.36 M
R&D Expense36.09 M33.84 M34.16 M26.82 M25.88 M27.26 M
Operating Expenses48.52 M43.72 M44.15 M38.76 M39.93 M41.62 M
Operating Income-48.37 M-44.93 M-45.37 M-38.54 M-39.71 M-41.39 M
Pretax Income-46.44 M-42.62 M-42.44 M-35.28 M-36.12 M-37.36 M
Tax Provision0.00-20.04 M-1.58 M560.00 K848.00 K591.00 K
Net Income-28.42 M-22.58 M-19.23 M-16.47 M-16.55 M-16.73 M
EPS (Basic)-0.15-0.16-0.14-0.12-0.13-0.13
EPS (Diluted)-0.15-0.16-0.14-0.12-0.13-0.13
Shares Outstanding186.56 M141.93 M140.44 M134.99 M130.73 M128.98 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
Prokidney Corp. (PROK) Financials: Revenue, Earnings & Balance Sheet | InsiderBuying.com